Rev Soc Bras Med Trop 2019 Apr 11;52:e20180246. Epub 2019 Apr 11.
Programa de Pós-Graduação em Biotecnologia Industrial, Universidade Tiradentes, Aracaju, SE, Brasil.
Introduction: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects.
Methods: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis.
Results: Our findings revealed a stable number of patents and scientific articles published over the past five years.
Conclusions: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.